Searched for
GENE THERAPY IN INDIA
Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...- India needs to remain attractive for innovation-led investment: Judith Love, NovartisWith an eye on India's blossoming market, Novartis is set to launch pioneering therapies, including radioligand and gene therapies. The com...
- AstraZeneca's Enhertu gets regulatory approval in India for first-line HER2-positive breast cancerAstraZeneca Pharma India has secured approval from India's drug regulator for its smart chemotherapy drug Enhertu. This allows for its impo...
- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- Tata-backed MedTherapy claims CAR-T breakthrough with one-day productionTata Sons-backed biotech startup MedTherapy said it has developed a next-generation CAR-T cell therapy manufacturing platform that can redu...
- Overhaul of drug regulator begins with recruitment plan for 1,500 specialistsIndia's pharmaceutical landscape is on the verge of transformation! The country’s drug regulatory body is gearing up for an overhaul with t...
- Drug applications with unanswered queries to be rejected within 30 daysThe message was conveyed through a public notice issued by The Central Drugs Standard Control Organisation (CDSCO) on May 4. It said applic...
- India should chart own path in treatment of rare diseases: ICMR chiefIndia is taking a groundbreaking step forward in the realm of rare disease care with a distinctive approach that champions local ingenuity ...
- Sun Pharma looks to outshine rival bids with $13 billion Organon offerSun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...
- Biotech startup Helex raises $3.5 million in round led by pi VenturesBluehill Capital, SOSV, and other global investors participated in the round. The Hyderabad- and US-based biotech startup will use the fund...
- Bharat Biotech invests Rs 600 cr to expand into cell, gene therapiesAs per Bharat Biotech, the facility will tackle scientific challenges such as targeted gene expression, immune system modulation, and long-...
- Bharat Biotech launches cell gene therapy facility, eyes product launch by 2028Bharat Biotech has invested $75 million in its first cell and gene therapy facility in Telangana, India, aiming to launch new therapies in ...
- Gene therapy for blood cancer shows 73 per cent response rate in clinical trialsResearchers, including those from the Indian Institute of Technology-Bombay and Tata Memorial Hospital, Mumbai, said in low and middle-inco...
- Driving innovation: India's foray into gene and cell therapiesIndia is progressing in cell and gene therapy. Research includes treatments for leukemia, hemophilia-A, sickle-cell anemia, and more.
- Miltenyi Biotec launches India operations, to open Centre in HyderabadGerman biomedical discovery provider Miltenyi Biotec is launching operations in India, opening its first office and setting up a Centre of ...
- Rs 17 crore for a single dose: Why Zolgensma is world's most expensive medicineThe high cost of Zolgensma, a one-time gene therapy used to treat spinal muscular atrophy (SMA) in children under two, is to limited patien...
- Affordable gene and cell therapies need of the hour: Dr Kapil Bharti, Scientific Director, National Eye InstituteLimitless potential for future global advancements in gene therapies is originating from India, said Dr David Gamm.
- Pharma companies' charity hope for kids with rare spinal disorderThe rare disease affects one in every 8,000 children. The bigger problem, according to parents and doctors, is the lack of awareness about ...
- How a Bengaluru lab is trying to fix the gene as therapy for hereditary health problemsAs Narayana Nethralaya is fronting it, the focus is on ocular (eye) diseases, though Ghosh’s own area of work is in muscular dystrophy.
- Indian-US team identifies genetic target for treating colorectal cancerAlso called colon, rectal or bowel cancer, CRC is the third most common cancer in men and the second in women worldwide.
Load More
